<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33769552</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5381</ISSN><JournalIssue CitedMedium="Internet"><Volume>179</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>British journal of pharmacology</Title><ISOAbbreviation>Br J Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Dual inhibition of CB<sub>1</sub> receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19.</ArticleTitle><Pagination><StartPage>2121</StartPage><EndPage>2127</EndPage><MedlinePgn>2121-2127</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bph.15461</ELocationID><Abstract><AbstractText>COVID-19 (SARS-CoV-2) causes multiple inflammatory complications, resulting not only in severe lung inflammation but also harm to other organs. Although the current focus is on the management of acute COVID-19, there is growing concern about long-term effects of COVID-19 (Long Covid), such as fibroproliferative changes in the lung, heart and kidney. Therefore, the identification of therapeutic targets not only for the management of acute COVID-19 but also for preventing Long Covid are needed, and would mitigate against long-lasting health burden and economic costs, in addition to saving lives. COVID-19 induces pathological changes via multiple pathways, which could be targeted simultaneously for optimal effect. We discuss the potential pathologic function of increased activity of the endocannabinoid/CB<sub>1</sub> receptor system and inducible NO synthase (iNOS). We advocate a polypharmacology approach, wherein a single chemical entity simultaneously interacts with CB<sub>1</sub> receptors and iNOS causing inhibition, as a potential therapeutic strategy for COVID-19-related health complications. LINKED ARTICLES: This article is part of a themed issue on The second wave: are we any closer to efficacious pharmacotherapy for COVID 19? (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.10/issuetoc.</AbstractText><CopyrightInformation>Published 2021. This article is a U.S. Government work and is in the public domain in the USA.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cinar</LastName><ForeName>Resat</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8597-7253</Identifier><AffiliationInfo><Affiliation>Section on Fibrotic Disorders, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Malliga R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunos</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Pharmacol</MedlineTA><NlmUniqueID>7502536</NlmUniqueID><ISSNLinking>0007-1188</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D063388">Endocannabinoids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063388" MajorTopicYN="N">Endocannabinoids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">iNOS inhibitor</Keyword><Keyword MajorTopicYN="N">peripheral CB1 antagonist</Keyword><Keyword MajorTopicYN="N">polypharmacology</Keyword><Keyword MajorTopicYN="N">pulmonary fibrosis</Keyword></KeywordList><CoiStatement>R.C., M.R.I. and G.K. are listed as co&#x2010;inventors on US patents covering hybrid CB<sub>1</sub> receptor/iNOS antagonists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>26</Day><Hour>12</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33769552</ArticleId><ArticleId IdType="pmc">PMC8251289</ArticleId><ArticleId IdType="doi">10.1111/bph.15461</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ackermann, M. , Verleden, S. E. , Kuehnel, M. , Haverich, A. , Welte, T. , Laenger, F. , Vanstapel, A. , Werlein, C. , Stark, H. , Tzankov, A. , Li, W. W. , Li, V. W. , Mentzer, S. J. , &amp; Jonigk, D. (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID&#x2010;19. The New England Journal of Medicine, 383, 120&#x2013;128. 10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Alon, M. H. , &amp; Saint&#x2010;Fleur, M. O. (2017). Synthetic cannabinoid induced acute respiratory depression: Case series and literature review. Respiratory Medicine Case Reports, 22, 137&#x2013;141. 10.1016/j.rmcr.2017.07.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmcr.2017.07.011</ArticleId><ArticleId IdType="pmc">PMC5547234</ArticleId><ArticleId IdType="pubmed">28794966</ArticleId></ArticleIdList></Reference><Reference><Citation>Batkai, S. , Jarai, Z. , Wagner, J. A. , Goparaju, S. K. , Varga, K. , Liu, J. , Wang, L. , Mirshahi, F. , Khanolkar, A. D. , Makriyannis, A. , Urbaschek, R. , Garcia, N. , Sanyal, A. J. , &amp; Kunos, G. (2001). Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nature Medicine, 7, 827&#x2013;832. 10.1038/89953</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/89953</ArticleId><ArticleId IdType="pubmed">11433348</ArticleId></ArticleIdList></Reference><Reference><Citation>Batkai, S. , Mukhopadhyay, P. , Harvey&#x2010;White, J. , Kechrid, R. , Pacher, P. , &amp; Kunos, G. (2007). Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. American Journal of Physiology Heart and Circulatory Physiology, 293, H1689&#x2013;H1695. 10.1152/ajpheart.00538.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00538.2007</ArticleId><ArticleId IdType="pmc">PMC2225474</ArticleId><ArticleId IdType="pubmed">17557913</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi, A. , Bernabei, R. , Landi, F. , &amp; Gemelli Against C&#x2010;P&#x2010;ACSG . (2020). Persistent symptoms in patients after acute COVID&#x2010;19. JAMA, 324, 603&#x2013;605. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco&#x2010;Sanchez, F. J. , Lopez&#x2010;Carmona, M. D. , Martinez&#x2010;Marcos, F. J. , Perez&#x2010;Belmonte, L. M. , Hidalgo&#x2010;Jimenez, A. , Buonaiuto, V. , Fern&#xe1;ndez, C. S. , Castro, S. J. F. , Luordo, D. , Fontan, P. M. P. , Encinar, J. C. B. , Gamboa, J. O. M. , de la Pe&#xf1;a Fern&#xe1;ndez, A. , Pe&#xf1;a, J. D. T. , Sol&#xe0;, J. F. , Lecumberri, J. J. N. , Mart&#xed;nez, F. A. , Espartero, M. E. G. , Ripper, C. J. , &#x2026; for the SEMI&#x2010;COVID&#x2010;19 Network . (2021). Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID&#x2010;19 regardless of diabetes status: Data from the Spanish SEMI&#x2010;COVID&#x2010;19 registry. Annals of Medicine, 53, 103&#x2013;116. 10.1080/07853890.2020.1836566</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2020.1836566</ArticleId><ArticleId IdType="pmc">PMC7651248</ArticleId><ArticleId IdType="pubmed">33063540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, X. J. , Li, K. , Xu, L. , Yu, Y. J. , Wu, B. , He, Y. L. , Zhao, W. E. , Li, D. , Luan, C. X. , Hu, L. , Wang, J. , Ding, J. J. , Yu, Y. F. , Li, J. X. , Tan, Z. M. , Liu, X. F. , Wei, D. , Zhang, Z. H. , Guo, X. J. , &#x2026; Chen, F. (2021). Novel insight from the first lung transplant of a COVID&#x2010;19 patient. European Journal of Clinical Investigation, 51, e13443. 10.1111/eci.13443</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13443</ArticleId><ArticleId IdType="pubmed">33131070</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinar, R. , Gochuico, B. R. , Iyer, M. R. , Jourdan, T. , Yokoyama, T. , Park, J. K. , Coffey, N. J. , Pri&#x2010;Chen, H. , Szanda, G. , Liu, Z. , Mackie, K. , Gahl, W. A. , &amp; Kunos, G. (2017). Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis. JCI Insight, 2(8), e92281. 10.1172/jci.insight.92281</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.92281</ArticleId><ArticleId IdType="pmc">PMC5396529</ArticleId><ArticleId IdType="pubmed">28422760</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinar, R. , Iyer, M. R. , &amp; Kunos, G. (2020). The therapeutic potential of second and third generation CB1R antagonists. Pharmacology &amp; Therapeutics, 208, 107477. 10.1016/j.pharmthera.2020.107477</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2020.107477</ArticleId><ArticleId IdType="pmc">PMC8605822</ArticleId><ArticleId IdType="pubmed">31926199</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo, A. C. , Davanzo, G. G. , Monteiro, L. B. , de Souza, G. F. , Muraro, S. P. , Virgilio&#x2010;da&#x2010;Silva, J. V. , Prodonoff, J. S. , Carregari, V. C. , de Biagi Junior, C. A. , Crunfli, F. , &amp; Restrepo, J. L. (2020). Elevated glucose levels favor SARS&#x2010;CoV&#x2010;2 infection and monocyte response through a HIF&#x2010;1alpha/glycolysis&#x2010;dependent axis. Cell Metabolism, 32, 437&#x2013;446. 10.1016/j.cmet.2020.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC7367032</ArticleId><ArticleId IdType="pubmed">32697943</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai, N. , Neyaz, A. , Szabolcs, A. , Shih, A. R. , Chen, J. H. , Thapar, V. , Nieman, L. T. , Solovyov, A. , Mehta, A. , Lieb, D. J. , Kulkarni, A. S. , Jaicks, C. , Xu, K. H. , Raabe, M. J. , Pinto, C. J. , Juric, D. , Chebib, I. , Colvin, R. B. , Kim, A. Y. , &#x2026; Deshpande, V. (2020). Temporal and spatial heterogeneity of host response to SARS&#x2010;CoV&#x2010;2 pulmonary infection. Nature Communications, 11, 6319. 10.1038/s41467-020-20139-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20139-7</ArticleId><ArticleId IdType="pmc">PMC7725958</ArticleId><ArticleId IdType="pubmed">33298930</ArticleId></ArticleIdList></Reference><Reference><Citation>Despres, J. P. , Golay, A. , &amp; Sjostrom, L. (2005). Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. The New England Journal of Medicine, 353, 2121&#x2013;2134. 10.1056/NEJMoa044537</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa044537</ArticleId><ArticleId IdType="pubmed">16291982</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvao&#x2010;Filho, B. , de Castro, J. T. , Figueiredo, M. M. , Rosmaninho, C. G. , Antonelli, L. , &amp; Gazzinelli, R. T. (2019). The emergence of pathogenic TNF/iNOS producing dendritic cells (Tip&#x2010;DCs) in a malaria model of acute respiratory distress syndrome (ARDS) is dependent on CCR4. Mucosal Immunology, 12, 312&#x2013;322. 10.1038/s41385-018-0093-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-018-0093-5</ArticleId><ArticleId IdType="pmc">PMC6375779</ArticleId><ArticleId IdType="pubmed">30337650</ArticleId></ArticleIdList></Reference><Reference><Citation>George, P. M. , Wells, A. U. , &amp; Jenkins, R. G. (2020). Pulmonary fibrosis and COVID&#x2010;19: The potential role for antifibrotic therapy. The Lancet Respiratory Medicine, 8, 807&#x2013;815. 10.1016/S2213-2600(20)30225-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30225-3</ArticleId><ArticleId IdType="pmc">PMC7228727</ArticleId><ArticleId IdType="pubmed">32422178</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik, T. J. , Mohiddin, S. A. , Dimarco, A. , Patel, V. , Savvatis, K. , Marelli&#x2010;Berg, F. M. , Madhur, M. S. , Tomaszewski, M. , Maffia, P. , D'Acquisto, F. , Nicklin, S. A. , Marian, A. J. , Nosalski, R. , Murray, E. C. , Guzik, B. , Berry, C. , Touyz, R. M. , Kreutz, R. , Wang, D. W. , &#x2026; McInnes, I. B. (2020). COVID&#x2010;19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research, 116, 1666&#x2013;1687. 10.1093/cvr/cvaa106</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Heemskerk, S. , Masereeuw, R. , Russel, F. G. , &amp; Pickkers, P. (2009). Selective iNOS inhibition for the treatment of sepsis&#x2010;induced acute kidney injury. Nature Reviews. Nephrology, 5, 629&#x2013;640. 10.1038/nrneph.2009.155</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2009.155</ArticleId><ArticleId IdType="pubmed">19786992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui, D. S. , Wong, K. T. , Ko, F. W. , Tam, L. S. , Chan, D. P. , Woo, J. , &amp; Sung, J. J. Y. (2005). The 1&#x2010;year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest, 128, 2247&#x2013;2261. 10.1378/chest.128.4.2247</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.4.2247</ArticleId><ArticleId IdType="pmc">PMC7094276</ArticleId><ArticleId IdType="pubmed">16236881</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung, I. F. , Lung, K. C. , Tso, E. Y. , Liu, R. , Chung, T. W. , Chu, M. Y. , Ng, Y. Y. , Lo, J. , Chan, J. , Tam, A. R. , &amp; Shum, H. P. (2020). Triple combination of interferon beta&#x2010;1b, lopinavir&#x2010;ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID&#x2010;19: An open&#x2010;label, randomised, phase 2 trial. Lancet, 395, 1695&#x2013;1704. 10.1016/S0140-6736(20)31042-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31042-4</ArticleId><ArticleId IdType="pmc">PMC7211500</ArticleId><ArticleId IdType="pubmed">32401715</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaw, J. E. , Tsuruta, M. , Oh, Y. , Schipilow, J. , Hirano, Y. , Ngan, D. A. , Suda, K. , Li, Y. , Oh, J. Y. , Moritani, K. , Tam, S. , Ford, N. , van Eeden, S. , Wright, J. L. , Man, S. F. P. , &amp; Sin, D. D. (2016). Lung exposure to lipopolysaccharide causes atherosclerotic plaque destabilisation. The European Respiratory Journal, 48, 205&#x2013;215. 10.1183/13993003.00972-2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00972-2015</ArticleId><ArticleId IdType="pubmed">27009170</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, A. , Neumann, P. H. , Peng, J. , James, J. , Russo, V. , MacDonald, H. , Gertzberg, N. , &amp; Feleder, C. (2015). The intracerebroventricular injection of rimonabant inhibits systemic lipopolysaccharide&#x2010;induced lung inflammation. Journal of Neuroimmunology, 286, 16&#x2013;24. 10.1016/j.jneuroim.2015.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4548270</ArticleId><ArticleId IdType="pubmed">26298320</ArticleId></ArticleIdList></Reference><Reference><Citation>Jourdan, T. , Godlewski, G. , Cinar, R. , Bertola, A. , Szanda, G. , Liu, J. , Tam, J. , Han, T. , Mukhopadhyay, B. , Skarulis, M. C. , Ju, C. , Aouadi, M. , Czech, M. P. , &amp; Kunos, G. (2013). Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nature Medicine, 19, 1132&#x2013;1140. 10.1038/nm.3265</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3265</ArticleId><ArticleId IdType="pmc">PMC4050982</ArticleId><ArticleId IdType="pubmed">23955712</ArticleId></ArticleIdList></Reference><Reference><Citation>Jourdan, T. , Park, J. K. , Varga, Z. V. , Paloczi, J. , Coffey, N. J. , Rosenberg, A. Z. , Godlewski, G. , Cinar, R. , Mackie, K. , Pacher, P. , &amp; Kunos, G. (2018). Cannabinoid&#x2010;1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy. Diabetes, Obesity &amp; Metabolism, 20, 698&#x2013;708. 10.1111/dom.13150</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.13150</ArticleId><ArticleId IdType="pubmed">29106063</ArticleId></ArticleIdList></Reference><Reference><Citation>Jourdan, T. , Szanda, G. , Rosenberg, A. Z. , Tam, J. , Earley, B. J. , Godlewski, G. , Cinar, R. , Liu, Z. , Liu, J. , Ju, C. , Pacher, P. , &amp; Kunos, G. (2014). Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy. Proceedings of the National Academy of Sciences of the United States of America, 111, E5420&#x2013;E5428. 10.1073/pnas.1419901111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1419901111</ArticleId><ArticleId IdType="pmc">PMC4273328</ArticleId><ArticleId IdType="pubmed">25422468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi, A. , Hashimoto, S. , Kooguchi, K. , Kitamura, Y. , Onodera, H. , Urata, Y. , &amp; Ashihara, T. (1998). Expression of inducible nitric oxide synthase and inflammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest, 113, 1632&#x2013;1639. 10.1378/chest.113.6.1632</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.113.6.1632</ArticleId><ArticleId IdType="pubmed">9631804</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides, S. , Schafer, K. , Koschnick, S. , &amp; Loskutoff, D. J. (2001). Leptin&#x2010;dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. The Journal of Clinical Investigation, 108, 1533&#x2013;1540. 10.1172/JCI13143</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI13143</ArticleId><ArticleId IdType="pmc">PMC209418</ArticleId><ArticleId IdType="pubmed">11714745</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccarrone, M. , Bab, I. , Biro, T. , Cabral, G. A. , Dey, S. K. , Di Marzo, V. , Konje, J. C. , Kunos, G. , Mechoulam, R. , Pacher, P. , &amp; Sharkey, K. A. (2015). Endocannabinoid signaling at the periphery: 50&#x2009;years after THC. Trends in Pharmacological Sciences, 36, 277&#x2013;296. 10.1016/j.tips.2015.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2015.02.008</ArticleId><ArticleId IdType="pmc">PMC4420685</ArticleId><ArticleId IdType="pubmed">25796370</ArticleId></ArticleIdList></Reference><Reference><Citation>Moritani, K. , Jaw, D. , Oh, Y. , Schiplow, J. , Ford, N. , Man, S. P. , &amp; Sin, D. D. (2017). Inhibition of INOS prevents atherosclerotic plaque destabilization related to LPS lung exposure: Results of novel 3D OPT imaging. American Journal of Respiratory and Critical Care Medicine, 195, A5229.</Citation></Reference><Reference><Citation>Onaivi, E. S. , &amp; Sharma, V. (2020). Cannabis for COVID&#x2010;19: Can cannabinoids quell the cytokine storm? Future Science OA, 6, FSO625. 10.2144/fsoa-2020-0124</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/fsoa-2020-0124</ArticleId><ArticleId IdType="pmc">PMC7451410</ArticleId><ArticleId IdType="pubmed">32974048</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacher, P. , Steffens, S. , Hasko, G. , Schindler, T. H. , &amp; Kunos, G. (2018). Cardiovascular effects of marijuana and synthetic cannabinoids: The good, the bad, and the ugly. Nature Reviews. Cardiology, 15, 151&#x2013;166. 10.1038/nrcardio.2017.130</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2017.130</ArticleId><ArticleId IdType="pubmed">28905873</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli, C. M. , Jones, S. A. , Yang, J. , Rajagopalan, H. , O'Donnell, L. , Chernyak, Y. , Tobin, K. A. , Cerfolio, R. J. , Francois, F. , &amp; Horwitz, L. I. (2020). Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study. BMJ, 369, m1966. 10.1136/bmj.m1966</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchi, G. , Mari, A. , Ricciardi, A. , Carucci, A. C. , Sinatti, G. , Cosimini, B. , di Norcia, M. , Iapadre, N. , Balsano, C. , &amp; Grimaldi, A. (2020). Three cases of COVID&#x2010;19 pneumonia in female patients in Italy who had pulmonary fibrosis on follow&#x2010;up lung computed tomography imaging. The American Journal of Case Reports, 21, e926921. 10.12659/AJCR.926921</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.926921</ArticleId><ArticleId IdType="pmc">PMC7690330</ArticleId><ArticleId IdType="pubmed">33219200</ArticleId></ArticleIdList></Reference><Reference><Citation>Proschak, E. , Stark, H. , &amp; Merk, D. (2019). Polypharmacology by design: A medicinal chemist's perspective on multitargeting compounds. Journal of Medicinal Chemistry, 62, 420&#x2013;444. 10.1021/acs.jmedchem.8b00760</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.8b00760</ArticleId><ArticleId IdType="pubmed">30035545</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajesh, M. , Batkai, S. , Kechrid, M. , Mukhopadhyay, P. , Lee, W. S. , Horvath, B. , Holovac, E. , Cinar, R. , Liaudet, L. , Mackie, K. , Hasko, G. , &amp; Pacher, P. (2012). Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes, 61, 716&#x2013;727. 10.2337/db11-0477</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db11-0477</ArticleId><ArticleId IdType="pmc">PMC3282820</ArticleId><ArticleId IdType="pubmed">22315315</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss, C. S. (2010). Cannabinoids and viral infections. Pharmaceuticals (Basel), 3, 1873&#x2013;1886. 10.3390/ph3061873</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph3061873</ArticleId><ArticleId IdType="pmc">PMC2903762</ArticleId><ArticleId IdType="pubmed">20634917</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanska, H. M. , Polak, J. M. , Coleman, R. A. , James, R. S. , Harmer, D. W. , Allen, J. C. , &amp; Bishop, A. E. (2002). iNOS gene upregulation is associated with the early proliferative response of human lung fibroblasts to cytokine stimulation. The Journal of Pathology, 197, 372&#x2013;379. 10.1002/path.1116</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1116</ArticleId><ArticleId IdType="pubmed">12115884</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi, F. , Tortora, C. , Argenziano, M. , Di Paola, A. , &amp; Punzo, F. (2020). Cannabinoid receptor type 2: A possible target in SARS&#x2010;CoV&#x2010;2 (CoV&#x2010;19) infection? International Journal of Molecular Sciences, 21(11), 3809. 10.3390/ijms21113809</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21113809</ArticleId><ArticleId IdType="pmc">PMC7312493</ArticleId><ArticleId IdType="pubmed">32471272</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz de Azua, I. , Mancini, G. , Srivastava, R. K. , Rey, A. A. , Cardinal, P. , Tedesco, L. , Zingaretti, C. M. , Sassmann, A. , Quarta, C. , Schwitter, C. , Conrad, A. , Wettschureck, N. , Vemuri, V. K. , Makriyannis, A. , Hartwig, J. , Mendez&#x2010;Lago, M. , Bindila, L. , Monory, K. , Giordano, A. , &#x2026; Lutz, B. (2017). Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages. The Journal of Clinical Investigation, 127, 4148&#x2013;4162. 10.1172/JCI83626</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI83626</ArticleId><ArticleId IdType="pmc">PMC5663356</ArticleId><ArticleId IdType="pubmed">29035280</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahidi, M. , Tay, E. S. , Read, S. A. , Ramezani&#x2010;Moghadam, M. , Chayama, K. , George, J. , &amp; Douglas, M. W. (2014). Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host&#x2010;targeting agents. The Journal of General Virology, 95, 2468&#x2013;2479. 10.1099/vir.0.067231-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.067231-0</ArticleId><ArticleId IdType="pubmed">25053565</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, P. , Sharma, P. , Nakade, U. P. , Sharma, A. , Gari, M. , Choudhury, S. , Shukla, A. , &amp; Garg, S. K. (2018). Endocannabinoid&#x2010;mediated modulation of Gq protein&#x2010;coupled receptor mediates vascular hyporeactivity to nor&#x2010;adrenaline during polymicrobial sepsis. Pharmacological Reports, 70, 1150&#x2013;1157. 10.1016/j.pharep.2018.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharep.2018.07.001</ArticleId><ArticleId IdType="pubmed">30317131</ArticleId></ArticleIdList></Reference><Reference><Citation>Southan, G. J. , Szabo, C. , &amp; Thiemermann, C. (1995). Isothioureas: Potent inhibitors of nitric oxide synthases with variable isoform selectivity. British Journal of Pharmacology, 114, 510&#x2013;516. 10.1111/j.1476-5381.1995.tb13256.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.1995.tb13256.x</ArticleId><ArticleId IdType="pmc">PMC1510225</ArticleId><ArticleId IdType="pubmed">7533622</ArticleId></ArticleIdList></Reference><Reference><Citation>Spagnolo, P. , Balestro, E. , Aliberti, S. , Cocconcelli, E. , Biondini, D. , Casa, G. D. , Sverzellati, N. , &amp; Maher, T. M. (2020). Pulmonary fibrosis secondary to COVID&#x2010;19: A call to arms? The Lancet Respiratory Medicine, 8, 750&#x2013;752. 10.1016/S2213-2600(20)30222-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30222-8</ArticleId><ArticleId IdType="pmc">PMC7228737</ArticleId><ArticleId IdType="pubmed">32422177</ArticleId></ArticleIdList></Reference><Reference><Citation>Tale, S. , Ghosh, S. , Meitei, S. P. , Kolli, M. , Garbhapu, A. K. , &amp; Pudi, S. (2020). Post&#x2010;COVID&#x2010;19 pneumonia pulmonary fibrosis. QJM, 113, 837&#x2013;838. 10.1093/qjmed/hcaa255</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa255</ArticleId><ArticleId IdType="pmc">PMC7454835</ArticleId><ArticleId IdType="pubmed">32814978</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam, J. (2016). The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases. Journal of Basic and Clinical Physiology and Pharmacology, 27, 267&#x2013;276. 10.1515/jbcpp-2015-0055</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jbcpp-2015-0055</ArticleId><ArticleId IdType="pubmed">26280171</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam, J. , Cinar, R. , Liu, J. , Godlewski, G. , Wesley, D. , Jourdan, T. , Szanda, G. , Mukhopadhyay, B. , Chedester, L. , Liow, J. S. , Innis, R. B. , Cheng, K. , Rice, K. C. , Deschamps, J. R. , Chorvat, R. J. , McElroy, J. F. , &amp; Kunos, G. (2012). Peripheral cannabinoid&#x2010;1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metabolism, 16, 167&#x2013;179. 10.1016/j.cmet.2012.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.07.002</ArticleId><ArticleId IdType="pmc">PMC3832894</ArticleId><ArticleId IdType="pubmed">22841573</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam, J. , Vemuri, V. K. , Liu, J. , Batkai, S. , Mukhopadhyay, B. , Godlewski, G. , Osei&#x2010;Hyiaman, D. , Ohnuma, S. , Ambudkar, S. V. , Pickel, J. , &amp; Makriyannis, A. (2010). Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. The Journal of Clinical Investigation, 120, 2953&#x2013;2966. 10.1172/JCI42551</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI42551</ArticleId><ArticleId IdType="pmc">PMC2912197</ArticleId><ArticleId IdType="pubmed">20664173</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi, P. , Tripathi, P. , Kashyap, L. , &amp; Singh, V. (2007). The role of nitric oxide in inflammatory reactions. FEMS Immunology and Medical Microbiology, 51, 443&#x2013;452. 10.1007/s10787-007-0013-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-007-0013-x</ArticleId><ArticleId IdType="pubmed">17903207</ArticleId></ArticleIdList></Reference><Reference><Citation>Udi, S. , Hinden, L. , Earley, B. , Drori, A. , Reuveni, N. , Hadar, R. , Cinar, R. , Nemirovski, A. , &amp; Tam, J. (2017). Proximal tubular cannabinoid&#x2010;1 receptor regulates obesity&#x2010;induced CKD. Journal of the American Society of Nephrology, 28, 3518&#x2013;3532. 10.1681/ASN.2016101085</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016101085</ArticleId><ArticleId IdType="pmc">PMC5698062</ArticleId><ArticleId IdType="pubmed">28860163</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Poorten, D. , Shahidi, M. , Tay, E. , Sesha, J. , Tran, K. , McLeod, D. , Milliken, J. S. , Ho, V. , Hebbard, L. W. , Douglas, M. W. , &amp; George, J. (2010). Hepatitis C virus induces the cannabinoid receptor 1. PLoS ONE, 5(9), e12841. 10.1371/journal.pone.0012841</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012841</ArticleId><ArticleId IdType="pmc">PMC2941472</ArticleId><ArticleId IdType="pubmed">20862263</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga, K. , Wagner, J. A. , Bridgen, D. T. , &amp; Kunos, G. (1998). Platelet&#x2010; and macrophage&#x2010;derived endogenous cannabinoids are involved in endotoxin&#x2010;induced hypotension. The FASEB Journal, 12, 1035&#x2013;1044. 10.1096/fasebj.12.11.1035</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.12.11.1035</ArticleId><ArticleId IdType="pubmed">9707176</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasarmidi, E. , Tsitoura, E. , Spandidos, D. A. , Tzanakis, N. , &amp; Antoniou, K. M. (2020). Pulmonary fibrosis in the aftermath of the COVID&#x2010;19 era (review). Experimental and Therapeutic Medicine, 20, 2557&#x2013;2560. 10.3892/etm.2020.8980</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2020.8980</ArticleId><ArticleId IdType="pmc">PMC7401793</ArticleId><ArticleId IdType="pubmed">32765748</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent, J. L. , Zhang, H. , Szabo, C. , &amp; Preiser, J. C. (2000). Effects of nitric oxide in septic shock. American Journal of Respiratory and Critical Care Medicine, 161, 1781&#x2013;1785. 10.1164/ajrccm.161.6.9812004</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.161.6.9812004</ArticleId><ArticleId IdType="pubmed">10852744</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue, Q. , Yan, Y. , Zhang, R. , &amp; Xiong, H. (2018). Regulation of iNOS on immune cells and its role in diseases. International Journal of Molecular Sciences, 19(12), 3805. 10.3390/ijms19123805</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19123805</ArticleId><ArticleId IdType="pmc">PMC6320759</ArticleId><ArticleId IdType="pubmed">30501075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye, Z. , Zhang, Y. , Wang, Y. , Huang, Z. , &amp; Song, B. (2020). Chest CT manifestations of new coronavirus disease 2019 (COVID&#x2010;19): A pictorial review. European Radiology, 30, 4381&#x2013;4389. 10.1007/s00330-020-06801-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-06801-0</ArticleId><ArticleId IdType="pmc">PMC7088323</ArticleId><ArticleId IdType="pubmed">32193638</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawatsky, C. N. , Abdalla, J. , &amp; Cinar, R. (2020). Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation. ERJ Open Research, 6, 121&#x2013;2020. 10.1183/23120541.00121-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00121-2020</ArticleId><ArticleId IdType="pmc">PMC7430153</ArticleId><ArticleId IdType="pubmed">32832534</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>